erythrosine has been researched along with HIV Coinfection in 20 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Excerpt | Relevance | Reference |
---|---|---|
"Montelukast was the most potent inhibitor (p<0." | 1.35 | Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir. ( Chakravarty, G; Honer Zu Bentrup, K; Mondal, D; Roy, U, 2009) |
"Five of these were affected by AIDS and five ARC (AIDS Related Complex)." | 1.28 | Vitreous fluorophotometric recordings in HIV infection. ( Baldi, A; Cellini, M, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (20.00) | 18.2507 |
2000's | 9 (45.00) | 29.6817 |
2010's | 6 (30.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors | Studies |
---|---|
Leibrand, CR | 1 |
Paris, JJ | 1 |
Jones, AM | 1 |
Ohene-Nyako, M | 1 |
Rademeyer, KM | 1 |
Nass, SR | 1 |
Kim, WK | 1 |
Knapp, PE | 1 |
Hauser, KF | 1 |
McRae, M | 1 |
Nakanjako, D | 1 |
Ssewanyana, I | 1 |
Nabatanzi, R | 1 |
Kiragga, A | 1 |
Kamya, MR | 1 |
Cao, H | 1 |
Mayanja-Kizza, H | 1 |
Howard, AL | 1 |
Pezzi, HM | 1 |
Beebe, DJ | 1 |
Berry, SM | 1 |
Zhang, Y | 1 |
Zhang, L | 1 |
Sun, J | 1 |
Liu, Y | 1 |
Ma, X | 1 |
Cui, S | 1 |
Ma, L | 1 |
Xi, JJ | 1 |
Jiang, X | 1 |
Minuesa, G | 1 |
Arimany-Nardi, C | 1 |
Erkizia, I | 1 |
Cedeño, S | 1 |
Moltó, J | 1 |
Clotet, B | 1 |
Pastor-Anglada, M | 1 |
Martinez-Picado, J | 1 |
Palma, PF | 1 |
Baggio, GL | 1 |
Spada, C | 1 |
Silva, RD | 1 |
Ferreira, SI | 1 |
Treitinger, A | 1 |
Chung, AW | 1 |
Rollman, E | 1 |
Center, RJ | 1 |
Kent, SJ | 2 |
Stratov, I | 1 |
Zaunders, JJ | 1 |
Munier, ML | 1 |
Seddiki, N | 1 |
Pett, S | 1 |
Ip, S | 1 |
Bailey, M | 1 |
Xu, Y | 1 |
Brown, K | 1 |
Dyer, WB | 1 |
Kim, M | 1 |
de Rose, R | 1 |
Jiang, L | 1 |
Breit, SN | 1 |
Emery, S | 1 |
Cunningham, AL | 1 |
Cooper, DA | 1 |
Kelleher, AD | 1 |
Roy, U | 1 |
Chakravarty, G | 1 |
Honer Zu Bentrup, K | 1 |
Mondal, D | 1 |
Schwartz, R | 1 |
Lu, Y | 1 |
Villines, D | 1 |
Sroussi, HY | 1 |
Fonteh, PN | 1 |
Keter, FK | 1 |
Meyer, D | 1 |
Gieseler, RK | 1 |
Marquitan, G | 1 |
Hahn, MJ | 1 |
Perdon, LA | 1 |
Driessen, WH | 1 |
Sullivan, SM | 1 |
Scolaro, MJ | 1 |
Brenchley, JM | 1 |
Douek, DC | 1 |
Godoy-Ramirez, K | 1 |
Mäkitalo, B | 1 |
Thorstensson, R | 1 |
Sandström, E | 1 |
Biberfeld, G | 1 |
Gaines, H | 1 |
Gómez-Román, VR | 1 |
Florese, RH | 1 |
Patterson, LJ | 1 |
Peng, B | 1 |
Venzon, D | 1 |
Aldrich, K | 1 |
Robert-Guroff, M | 1 |
Yu, J | 1 |
Chen, H | 1 |
Horton, H | 1 |
Bansal, A | 1 |
McElrath, JM | 1 |
Reichman, R | 1 |
Goepfert, P | 1 |
Jin, X | 1 |
Yang, G | 1 |
Olson, JC | 1 |
Pu, R | 1 |
Vyas, GN | 1 |
McKinney, DM | 1 |
Lewinsohn, DA | 1 |
Riddell, SR | 1 |
Greenberg, PD | 1 |
Mosier, DE | 1 |
Gulakowski, RJ | 1 |
McMahon, JB | 1 |
Staley, PG | 1 |
Moran, RA | 1 |
Boyd, MR | 1 |
Cellini, M | 1 |
Baldi, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Nickel Desensitization Using Topical Therapy[NCT01413477] | 24 participants (Anticipated) | Interventional | 2011-08-31 | Not yet recruiting | |||
[NCT00005303] | 0 participants | Observational | 1986-09-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
20 other studies available for erythrosine and HIV Coinfection
Article | Year |
---|---|
Independent actions by HIV-1 Tat and morphine to increase recruitment of monocyte-derived macrophages into the brain in a region-specific manner.
Topics: Animals; Corpus Striatum; Dextrans; Fluoresceins; HIV Infections; HIV-1; Humans; Macrophages; Mice; | 2022 |
Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort.
Topics: Adult; Antigens; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD8-Positive T-L | 2013 |
Exclusion-Based Capture and Enumeration of CD4+ T Cells from Whole Blood for Low-Resource Settings.
Topics: Acquired Immunodeficiency Syndrome; Automation, Laboratory; Biomarkers; CD4 Lymphocyte Count; CD4-Po | 2014 |
Point-of-care multiplexed assays of nucleic acids using microcapillary-based loop-mediated isothermal amplification.
Topics: Electricity; Equipment Design; Fluoresceins; Fluorescent Dyes; HIV Infections; HIV-1; Humans; Influe | 2014 |
P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.
Topics: Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily B; Benzylidene Compounds; CD4-Positive | 2016 |
Evaluation of annexin V and Calcein-AM as markers of mononuclear cell apoptosis during human immunodeficiency virus infection.
Topics: Annexin A5; Apoptosis; Biomarkers; Cell Membrane Permeability; Ethidium; Flow Cytometry; Fluorescein | 2008 |
Rapid degranulation of NK cells following activation by HIV-specific antibodies.
Topics: Adult; Antibody Specificity; Antibody-Dependent Cell Cytotoxicity; Cell Degranulation; Cell Line, Tr | 2009 |
High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40).
Topics: Adult; Amino Acid Sequence; Animals; CD4-Positive T-Lymphocytes; Cells, Cultured; Chronic Disease; E | 2009 |
Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Antineoplastic Agents, Phytogenic; Biological Transport; C | 2009 |
Effect of human immunodeficiency virus infection on S100A8/A9 inhibition of peripheral neutrophils oxidative metabolism.
Topics: AIDS-Related Opportunistic Infections; Calgranulin A; Calgranulin B; Case-Control Studies; Cells, Cu | 2010 |
New bis(thiosemicarbazonate) gold(III) complexes inhibit HIV replication at cytostatic concentrations: potential for incorporation into virostatic cocktails.
Topics: Anti-HIV Agents; CD4 Antigens; CD4-Positive T-Lymphocytes; Cell Proliferation; Cell Survival; Coordi | 2011 |
DC-SIGN-specific liposomal targeting and selective intracellular compound delivery to human myeloid dendritic cells: implications for HIV disease.
Topics: Cell Adhesion Molecules; Cells, Cultured; Dendritic Cells; Drug Delivery Systems; Flow Cytometry; Fl | 2004 |
Flow cytometric analysis of human antigen-specific T-cell proliferation.
Topics: CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Cellular Senescence; Flo | 2004 |
A novel assay for assessment of HIV-specific cytotoxicity by multiparameter flow cytometry.
Topics: Cells, Cultured; Chromium; Cytotoxicity, Immunologic; Flow Cytometry; Fluoresceins; HIV Antigens; HI | 2005 |
A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.
Topics: AIDS Vaccines; Animals; Antibodies, Monoclonal; Antibodies, Viral; Antibody-Dependent Cell Cytotoxic | 2006 |
Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection.
Topics: Amino Acid Sequence; CD8-Positive T-Lymphocytes; Cell Division; Cells, Cultured; Chronic Disease; Cy | 2006 |
Flow cytometric detection of human immunodeficiency virus type 1 proviral DNA by the polymerase chain reaction incorporating digoxigenin- or fluorescein-labeled dUTP.
Topics: Base Sequence; Deoxyuracil Nucleotides; Digoxigenin; DNA, Viral; Flow Cytometry; Fluoresceins; Fluor | 1995 |
The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets.
Topics: Adoptive Transfer; Amino Acid Sequence; Animals; Base Sequence; Clone Cells; Epitopes, T-Lymphocyte; | 1999 |
A semiautomated multiparameter approach for anti-HIV drug screening.
Topics: Antiviral Agents; Drug Evaluation, Preclinical; Evaluation Studies as Topic; Fluoresceins; HIV; HIV | 1991 |
Vitreous fluorophotometric recordings in HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Blood-Retinal Barrier; Eye Diseases | 1991 |